Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review
Chemistry & Biodiversity · 2024-06 · 21 (6)
DOI: 10.1002/cbdv.202302032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 06.05.2024. Verfasst von Congying Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, No. 55 Daxuecheng S…. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Science and Technology, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Honokiol (HK) is a traditional Chinese herbal bioactive compound that originates mainly from the Magnolia species , traditionally used to treat anxiety and stroke, as well as alleviation of flu symptoms. This natural product and its derivatives displayed diverse biological activities, including anticancer, antioxidant, anti‐inflammatory, neuroprotective, and antimicrobial activities. However, its poor bioavailability and pharmacological activity require primary consideration in the development of HK‐based drugs. Recent innovative HK formulations based on the nanotechnology approach allowed for improvement in both bioavailability and therapeutic efficacy. Chemical derivation and drug combination are also effective strategies to ameliorate the drawbacks of HK. In recent years, studies on HK derivatives and compositions have made great progress in the treatment of cancer, inflammation, bacterial infection, cardiovascular, and cerebrovascular diseases, demonstrating better activity than HK. The objective of this review is an examination of the recent developments in the field of pharmacological activity of HK and its drug‐related issues, and approaches to improve its physicochemical and biological properties, including solubility, stability, and bioavailability. Recent patents and the ongoing clinical trials in HK are also summarized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, No. 55 Daxuecheng South Road, Shapingba, Chongqing, 401331, P. R. China.
- Chongqing Energy College, No. 2 Fuxing Avenue, Shuangfu New District, Jiangjin District, Chongqing, 402260, P. R. China.
- College of Pharmacy, Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, P. R. China.
ORCID-Profile: Chao Huang
Förderung
- National Natural Science Foundation of China
- Chongqing Science and Technology
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Pan, C., Li, Q., Xiong, S., Yang, Y., Yang, Y., Huang, C., & Wang, Z. P. (2024). Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review. Chemistry & Biodiversity, 21(6). https://doi.org/10.1002/cbdv.202302032
Vancouver
Pan C, Li Q, Xiong S, Yang Y, Yang Y, Huang C, et al. Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review. Chemistry & Biodiversity. 2024;21(6). doi:10.1002/cbdv.202302032
BibTeX
@article{Pan2024,
author = {Pan, Congying and Li, Qing and Xiong, Shuxin and Yang, Yan and Yang, Yi and Huang, Chao and Wang, Zhi-Peng},
title = {Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review},
journal = {Chemistry & Biodiversity},
year = {2024},
volume = {21},
number = {6},
doi = {10.1002/cbdv.202302032}
}
EUVIMED